Short-acting beta(2)-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III

Creative Commons License

Yorgancioglu A., Aksu K., NAYCI S., EDİGER D., Mungan D., Gul U., ...Daha Fazla

BMC PULMONARY MEDICINE, cilt.22, sa.1, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1186/s12890-022-02008-9
  • Dergi Adı: BMC PULMONARY MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Anahtar Kelimeler: Asthma, Exacerbations, Turkey, Prescriptions, Short-acting beta(2)-agonists, PREVALENCE, SEVERITY, OBESITY, IMPACT
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background: Over-reliance on short-acting beta(2)-agonists (SABAs) is associated with poor asthma outcomes. However, the extent of SABA use in Turkey is unclear owing to a lack of comprehensive healthcare databases. Here, we describe the demographics, disease characteristics and treatment patterns from the Turkish cohort of the SABA use IN Asthma (SABINA) III study.